Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Carrier Screening - Comprehensive Panel (145 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 185 | 145 |
|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
Centogene AG - the Rare Disease Company Germany | 243 | 238 |
|
EVC2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Carrier Screening Guidelines-Based Panel Ambry Genetics United States | 199 | 164 |
|
Centogene AG - the Rare Disease Company Germany | 498 | 498 |
|
Centogene AG - the Rare Disease Company Germany | 499 | 499 |
|
Centogene AG - the Rare Disease Company Germany | 289 | 275 |
|
Centogene AG - the Rare Disease Company Germany | 740 | 728 |
|
Centogene AG - the Rare Disease Company Germany | 829 | 848 |
|
Invitae Facial Dysostosis and Frontonasal Dysplasia Panel Invitae United States | 44 | 28 |
|
Invitae Skeletal Disorders Panel Invitae United States | 624 | 349 |
|
Invitae Limb and Digital Malformations Panel Invitae United States | 356 | 177 |
|
Ellis-van Creveld syndrome and Weyers acrofacial dysostosis NGS Panel HNL Genomics Connective Tissue Gene Tests United States | 2 | 2 |
|
Ellis-van Creveld syndrome and Weyers acrofacial dysostosis Comprehensive Panel HNL Genomics Connective Tissue Gene Tests United States | 2 | 2 |
|
Ellis-van Creveld syndrome and Weyers acrofacial dysostosis Deletion / Duplication Panel HNL Genomics Connective Tissue Gene Tests United States | 2 | 2 |
|
Polydactyly and Syndactyly Panel PreventionGenetics, part of Exact Sciences United States | 320 | 231 |
|
PreventionGenetics, part of Exact Sciences United States | 231 | 139 |
|
Genome-Nilou Lab Iran | 110 | 146 |
|
Ellis-van Creveld syndrome, 225500, Autosomal recessive; EVC (Ellis Van Creveld syndrome) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.